Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.
Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.
TORTOLA, British Virgin Islands, Aug. 7, 2025 /PRNewswire/ -- Worldwide Stablecoin Payment Network (WSPN), a leading stablecoin infrastructure provider with its flagship product stablecoin WUSD,...
SEOUL, South Korea, Aug. 6, 2025 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today its participation in K-Display 2025...
TORONTO, Aug. 6, 2025 /CNW/ - Allied Gold Corporation (TSX: AAUC) (NYSE: AAUC) ("Allied" or the "Company") reports second quarter of 2025 production of...
TORONTO, Aug. 6, 2025 /PRNewswire/ - Allied Gold Corporation (TSX: AAUC) (NYSE: AAUC) ("Allied" or the "Company") reports second quarter of 2025 production of...
Qualified Investors and Analysts Can Register at No Cost at www.enercomdenver.com
Deadline to Submit One-on-One Meeting Requests to Presenting Companies is Friday, August 8th
Registration still...
VANCOUVER, BC, Aug. 6, 2025 /CNW/ - A hearing has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) pursuant to...
The Biomarkers Market is anticipated to expand at a rapid pace due to the increasing demand for personalized medicine, rising prevalence of chronic and...
DUBLIN, Ireland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a provider of integrated energy solutions, today announced that it has received formal confirmation from the Hearings Advisor (the “Hearings Advisor”) of the Office of the General Counsel of the Nasdaq Hearings Panel (the “Nasdaq Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with all applicable listing requirements.
SAN ANTONIO, Aug. 5, 2025 /PRNewswire/ -- A groundbreaking multicenter clinical study published on July 30 in JAMA Surgery confirms the powerful diagnostic performance...